Elixir

Elixir Pharmaceuticals, a Cambridge, MA-based biopharmaceutical company focuses on developing and commercializing drugs to treat and prevent metabolic disease and age-related diseases, ultimately extending the quality and length of human life.

www.elixirpharm.com

Recent News

Elixir Issuance of SIRT Patent, Business Wire, April 28, 2008

Elixir Establishes National Diabetes Advisory Board, Business Wire, April 9, 2008

Elixir Completes Enrollment in Pivotal Phase III Clinical Trial for New Diabetes Drug, Business Wire, March 25, 2008

Elixir Names Presents New Data on Ghrelin Inhibition at Keystone Meeting, Release, February 22, 2008

Elixir Files for Proposed IPO, Genetic Engineering & Biotechnology News, September 24, 2007

Elixir Names Paul M. Martha, MD as Chief Medical Officer, Release, October 25, 2007

Elixir Taps Chief Medical Officer, Boston Business Journal, October 25, 2007